Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
2023 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Works of J. Hureaux being referenced
Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)
2011
The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| J. Hureaux | 654 | 519 | 252 | 61 | 1.3k | |
| Nadezhda V. Koshkina | 578 | 350 | 592 | 38 | 1.5k | |
| Yusuke Kono | 315 | 494 | 249 | 91 | 1.1k | |
| Yating Sun | 282 | 372 | 517 | 59 | 1.5k | |
| Marije Slingerland | 282 | 431 | 469 | 84 | 1.3k | |
| Qi Yang | 250 | 215 | 683 | 69 | 1.7k | |
| Wolfgang Hohenforst‐Schmidt | 921 | 376 | 335 | 121 | 1.7k | |
| Woo Kyun Bae | 400 | 566 | 534 | 133 | 1.6k | |
| Hideki Hirabayashi | 140 | 510 | 344 | 97 | 1.3k | |
| Mafalda Videira | 396 | 376 | 712 | 45 | 1.7k | |
| Ryoichi Wada | 439 | 497 | 93 | 43 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...